This BRAF mutation was detected (i) in the primary tumor, (ii) in all the CTC lines, (iii) the lymph node metastasis, and also (iv) in tumor xenografts obtained by injection of CTC-MCC-41 cells13. This evidence concerns the gene BRAF and neoplasm.